Article Text


PWE-074 Tissue Inhibitor Of Metalloproteinase (timp)-3 Reduces Pro-inflammatory Cytokine Production By Ulcerative Colitis Mucosa Cultured Ex Vivo
  1. IM Bell,
  2. F Ammoscato,
  3. P Biancheri,
  4. R Curciarello,
  5. T Macdonald
  1. CIID, Blizard Institute, Barts and The London School of Medicine and Dentistry, London, UK


Introduction Interleukin (IL)-1b, IL-6, IL-8 and tumour necrosis factor (TNF)-a, are elevated in the inflamed mucosa of patients with ulcerative colitis and play a central role in driving the pro-inflammatory immune response in this condition. TNF-a is cleaved from the cell surface by TNF-a converting enzyme (TACE), which is inhibited by tissue inhibitor of Metalloproteinase (TIMP)-3. We studied whether the addition of TIMP-3 to inflamed colonic biopsies from ulcerative colitis patients reduced the release of the pro-inflammatory cytokines TNF-a, IL-1b, IL-6 and IL-8.

Methods Colonic biopsies were obtained from macroscopically inflamed areas of 4 patients with ulcerative colitis undergoing colonoscopy for a disease flare. Biopsies were then cultured ex vivo for 24 h in 300 ul of serum free HL-1 medium in the absence or presence of recombinant human TIMP-3 (100 ng/ml). The concentration of TNF-a, IL-1β, IL-6 and IL-8 were measured in culture supernatants by ELISA.

Results Culture with TIMP-3 significantly reduced TNF-a production by inflamed ulcerative colitis biopsies cultured ex vivo (from 1365 ug/ml in the absence of TIMP-3 to 45 ug/ml after TIMP-3 addition). Furthermore, the addition of TIMP-3 significantly reduced IL-1b production by inflamed ulcerative colitis biopsies (from 776 to 261 ug/ml). There was a trend in the reduction of IL-6 (from 3018 to 2702 ug/ml), which did not reach statistic significance, and no significant change in IL-8 production (from 30812 to 29114.5 ug/ml).

Conclusion TIMP-3 administration not only causes a reduction in TNF-a via TACE inhibition but also IL-1β. This raises the possibility of its use therapeutically in the treatment of ulcerative colitis.

Disclosure of Interest None Declared.

Statistics from

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.